GESTIÓN EN SALUD PÚBLICA: Regulatory Perspectives for Development of Drugs for Treatment of NASH - 01/29/2021 - 01/29/2021 | FDA

viernes, 8 de enero de 2021

Regulatory Perspectives for Development of Drugs for Treatment of NASH - 01/29/2021 - 01/29/2021 | FDA

Regulatory Perspectives for Development of Drugs for Treatment of NASH - 01/29/2021 - 01/29/2021 | FDA

No hay comentarios:

Publicar un comentario

Suscribirse a: Enviar comentarios (Atom)